CVS Health Aktie 548525 / US1266501006
87.77
USD
0.10
USD
0.11%
22:00:00
NDN
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | Ausblick | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.70 |
| Vanguard Group, Inc. (Subfiler) | 8.40 |
| The Vanguard Group, Inc. | 8.31 |
| Capital Research & Management Co. (World Investors) | 4.63 |
| State Street Corp. | 4.44 |
| Vanguard Total Stock Market Index Fund | 3.04 |
| Washington Mutual Investors Fund | 2.47 |
| BlackRock Fund Advisors | 2.43 |
| Vanguard 500 Index Fund | 2.31 |
| BlackRock Institutional Trust Co. NA | 2.15 |
| Capital Research & Management Co. (International Investors) | 1.97 |
| Geode Capital Management LLC | 1.78 |
| Morgan Stanley Smith Barney LLC | 1.66 |
| American Balanced Fund | 1.59 |
| JPMorgan Investment Management, Inc. | 1.53 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 295'000 | 290'000 | 300'000 | 300'000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.66 | 0.88 | 0.90 | 0.97 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 45'243 | 50'302 | 56'369 | 60'008 |
| Summe Anlagevermögen | 131'654 | 152'866 | 154'431 | 151'074 |
| Summe Aktiva | 198'210 | 224'294 | 238'489 | 240'496 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 73'429 | 89'002 | 85'042 | 75'999 |
| Summe Fremdkapital | 139'667 | 160'124 | 168'788 | 165'115 |
| Summe Eigenkapital | 58'543 | 64'170 | 69'701 | 75'381 |
| Summe Passiva | 198'210 | 224'294 | 238'489 | 240'496 |
Adresse
| One CVS Drive, 02895 Woonsocket | |
| Telefon | +1 (401) 765-1500 |
| URL | http://www.cvshealth.com |
Management
|
Alan M. Lotvin
President-Pharmacy Services & Executive VP |
|
Alec Cunningham
Executive Vice President |
|
Alecia A. DeCoudreaux
Independent Director |
|
Anne M. Finucane
Independent Director |
|
Bryan Cook
Regional Director-Real Estate |
|
C. David Brown
Independent Director |
|
Carol Ann DeNale
Treasurer & Senior Vice President |
|
Chad Edwards
Strategic Projects Director-Retail |
|
Charles Golden
SVP-Construction & Property Administration |
|
Colleen M. McIntosh
Secretary, Chief Governance Officer & Senior VP |
|
Danni Gallagher
Vice President-Construction |
|
David A. Falkowski
Chief Compliance Officer & Executive VP |
|
David Berman
Director-Real Estate Metro NY |
|
Deborah LeClerc
Coordinator-Real Estate |
|
Edward J. Ludwig
Independent Director |
|
Fernando G. Aguirre
Independent Director |
|
Holly Jensen
Director-Real Estate & Executive Advisor |
|
James D. Clark
Chief Accounting Officer, Senior VP & Controller |
|
Jason L. Monroe
Sales Manager |
|
Jean-Pierre Millon
Independent Director |
|
Jeffrey R. Balser
Independent Director |
|
Jenice Tom
Director-Real Estate Market Research & Analytics |
|
Karen S. Lynch
President, Chief Executive Officer & Director |
|
Larry Webb
Director-Real Estate |
|
Laurence McGrath
SVP-Business Development & Investor Relations |
|
Laurie P. Havanec
Chief People Officer & Executive Vice President |
|
Lisa Rometty
President-CVS Kidney Care |
|
Mary L. Schapiro
Independent Director |
|
Matthew Tamke
Director-OTC Health Solutions |
|
Melissa A. Schulman
Senior Vice President-Government & Public Affairs |
|
Michael Kurimcak
Vice President-Real Estate |
|
Michelle A. Peluso
Chief Customer Officer, EVP & Co-President-Retail |
|
Nancy-Ann M. DeParle
Independent Director |
|
Norman de Greve
Chief Marketing Officer & Senior Vice President |
|
Per G. H. Lofberg
Executive Vice President |
|
Prem S. Shah
Chief Pharmacy Officer, EVP & Co-President-Retail |
|
Richard E. Govignon
Pharmacist |
|
Robert Holtzman
Regional Real Estate Manager |
|
Robin Peterson
Real Estate Director |
|
Roger N. Farah
Chairman |
|
Samrat S. Khichi
EVP, Chief Policy Officer & General Counsel |
|
Shawn M. Guertin
Chief Financial Officer & Executive Vice President |
|
Sreekanth Chaguturu
Chief Medical Officer & Executive Vice President |
|
Stephen Frumento
VP-Real Estate & Corporate Acquisitions |
|
Stephen LaBonge
Regional Director-Real Estate |
|
Thomas S. Moffatt
Vice President & Senior Legal Counsel |
|
Tilak Mandadi
EVP, Chief Data, Digital & Technology Officer |
|
Todd Galusha
Real Estate Advisor |
|
Tracey Drake Weber
Senior VP-Digital Products, UX & Operations |
|
Violetta Ostafin
Chief Strategy Officer & Executive Vice President |
|
William C. Weldon
Independent Director |
